Alefacept is effective and has a rapid onset of action in acute graft-versus-host-disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1524, 2006-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for acute graft-versus-host disease

By Khaled Yasser Reddy Pavan Krijanovski Oleg

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 219-232

Informa Healthcare

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

Denileukin diftitox has promising activity in graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease

By Bauters T.

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 350-352

Springer Publishing Company

Access to resources Recommend Favorite

Ciclosporin/methotrexate/prednisolone withdrawal: Acute graft-versus-host disease and kidney disorders: case report

Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite